<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02707822</url>
  </required_header>
  <id_info>
    <org_study_id>201512005RINC</org_study_id>
    <nct_id>NCT02707822</nct_id>
  </id_info>
  <brief_title>The Influence of ABCB1、CYP3A4、CYP3A5、POR Genetic Polymorphism and Other Factors on Tacrolimus Blood Concentration</brief_title>
  <official_title>The Influence of ABCB1、CYP3A4、CYP3A5、POR Genetic Polymorphism and Other Factors on Tacrolimus Blood Concentration</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to identify factors that may influence tacrolimus (TAC)
      pharmacokinetics, and the impact of gene polymorphism (ABCB1, CYP3A4, CYP3A5, POR) on
      pharmacokinetics of TAC in Taiwanese.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      TAC is one of the most important immunosuppressive agents for organ transplantation. In some
      patients the dose and concentration of TAC are difficult to adjust because of its narrow
      therapeutic index and variable pharmacokinetics.

      Many factors affect the pharmacokinetics of TAC. Literature suggests that ABCB1, CYP3A4,
      CYP3A5, POR gene polymorphisms may affect the pharmacokinetics of TAC. In addition, the
      distribution of TAC is affected by hematocrit and albumin concentrations. The
      pharmacokinetics of TAC may also be affected by total protein, total bilirubin, creatinine,
      AST, ALT, gender, age, drug interactions, and so on.

      This study intends to analyze the influence of various factors, including drugs, on the
      pharmacokinetics of TAC.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
  </study_design_info>
  <primary_outcome>
    <measure>Dose-normalized tacrolimus concentration</measure>
    <time_frame>Within the first 6 months post-transplantation</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">440</enrollment>
  <condition>Kidney Transplantation</condition>
  <condition>Liver Transplantation</condition>
  <arm_group>
    <arm_group_label>kidney or liver transplantation</arm_group_label>
    <description>Renal or liver transplant recipients with tacrolimus as immunosuppressive drugs.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Clinical and genetic factors</intervention_name>
    <arm_group_label>kidney or liver transplantation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Renal or liver transplant recipients who underwent transplantation at National Taiwan
        University Hospital, and were treated with tacrolimus.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  kidney transplants or liver transplants

          -  20 - 65 years old

          -  receiving tacrolimus as immunosuppressive drugs

        Exclusion Criteria:

          -  Human immunodeficiency virus-positive status

          -  Retransplantation or multiorgan transplantation

          -  non-Asian
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Meng-Kun Tsai</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fe-Lin Lin Wu</last_name>
    <phone>+886-2-3366 8784</phone>
    <email>flwu@ntu.edu.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meng-Kun Tsai</last_name>
      <phone>+886-972651461</phone>
      <email>mengkuntsai@ntu.edu.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 9, 2016</study_first_submitted>
  <study_first_submitted_qc>March 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 14, 2016</study_first_posted>
  <last_update_submitted>March 9, 2016</last_update_submitted>
  <last_update_submitted_qc>March 9, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 14, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>tacrolimus</keyword>
  <keyword>pharmacokinetics</keyword>
  <keyword>gene polymorphism</keyword>
  <keyword>clinical factors</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tacrolimus</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

